417 related articles for article (PubMed ID: 30136337)
1. The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndrome.
Hod K; Dekel R; Aviv Cohen N; Sperber A; Ron Y; Boaz M; Berliner S; Maharshak N
Neurogastroenterol Motil; 2018 Dec; 30(12):e13456. PubMed ID: 30136337
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS.
Hod K; Sperber AD; Ron Y; Boaz M; Dickman R; Berliner S; Halpern Z; Maharshak N; Dekel R
Neurogastroenterol Motil; 2017 Jul; 29(7):. PubMed ID: 28271623
[TBL] [Abstract][Full Text] [Related]
3. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
4. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
[TBL] [Abstract][Full Text] [Related]
5. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
[TBL] [Abstract][Full Text] [Related]
6. The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Sun YY; Li M; Li YY; Li LX; Zhai WZ; Wang P; Yang XX; Gu X; Song LJ; Li Z; Zuo XL; Li YQ
Sci Rep; 2018 Feb; 8(1):2964. PubMed ID: 29445178
[TBL] [Abstract][Full Text] [Related]
7. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
[TBL] [Abstract][Full Text] [Related]
9. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
[TBL] [Abstract][Full Text] [Related]
10. Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study.
Yoon JY; Cha JM; Oh JK; Tan PL; Kim SH; Kwak MS; Jeon JW; Shin HP
Dig Dis Sci; 2018 Oct; 63(10):2754-2764. PubMed ID: 29876777
[TBL] [Abstract][Full Text] [Related]
11. The Effectiveness of Synbiotic Preparation Containing
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients With Persistent IBS-type Symptoms: A Randomized, Double-Blind, Placebo-controlled, Multicenter Trial.
Francavilla R; Piccolo M; Francavilla A; Polimeno L; Semeraro F; Cristofori F; Castellaneta S; Barone M; Indrio F; Gobbetti M; De Angelis M
J Clin Gastroenterol; 2019 Mar; 53(3):e117-e125. PubMed ID: 29688915
[TBL] [Abstract][Full Text] [Related]
13. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
Pinto-Sanchez MI; Hall GB; Ghajar K; Nardelli A; Bolino C; Lau JT; Martin FP; Cominetti O; Welsh C; Rieder A; Traynor J; Gregory C; De Palma G; Pigrau M; Ford AC; Macri J; Berger B; Bergonzelli G; Surette MG; Collins SM; Moayyedi P; Bercik P
Gastroenterology; 2017 Aug; 153(2):448-459.e8. PubMed ID: 28483500
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and dose response of
Martoni CJ; Srivastava S; Damholt A; Leyer GJ
World J Gastroenterol; 2023 Jul; 29(28):4451-4465. PubMed ID: 37576702
[TBL] [Abstract][Full Text] [Related]
15. Baseline gut microbial profiles are associated with the efficacy of
Hong G; Li Y; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
Scand J Gastroenterol; 2023 Apr; 58(4):339-348. PubMed ID: 36281578
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial.
Anderle K; Wolzt M; Moser G; Keip B; Peter J; Meisslitzer C; Gouya G; Freissmuth M; Tschegg C
World J Gastroenterol; 2022 Dec; 28(46):6573-6588. PubMed ID: 36569277
[TBL] [Abstract][Full Text] [Related]
17. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
Li G; Yang M; Jin Y; Li Y; Qian W; Xiong H; Song J; Hou X
J Gastroenterol Hepatol; 2018 Jun; 33(6):1220-1226. PubMed ID: 29194775
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial.
Han K; Wang J; Seo JG; Kim H
J Gastroenterol; 2017 Apr; 52(4):432-443. PubMed ID: 27178566
[TBL] [Abstract][Full Text] [Related]
19. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
20.
Gargari G; Mantegazza G; Cremon C; Taverniti V; Valenza A; Barbaro MR; Marasco G; Duncan R; Fiore W; Ferrari R; De Vitis V; Barbara G; Guglielmetti S
Gut Microbes; 2024; 16(1):2298246. PubMed ID: 38178601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]